Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research - United Kingdom
doi 10.12688/f1000research.10624.3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Adaptive Dose Finding Based Ont-Statistic for Dose–response Trials

Statistics in Medicine
EpidemiologyStatisticsProbability
2008English

“Maximum Tolerated Dose” Versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults With Sickle Cell Anemia

American Journal of Hematology
Hematology
2019English

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2013English

Robust EM Continual Reassessment Method in Oncology Dose Finding

Journal of the American Statistical Association
UncertaintyStatisticsProbability
2011English

An Application of Reinforced Urn Processes to Determining Maximum Tolerated Dose

Statistics and Probability Letters
UncertaintyStatisticsProbability
2007English

Dose Finding Versus Speed in Seamless Immuno-Oncology Drug Development

Journal of Clinical Pharmacology
Pharmacology
2017English

Correction: The Impact of Non-Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials

Clinical Cancer Research
Cancer ResearchOncology
2012English

Supplemental Information 23: Dose Titration Assay.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy